Literature DB >> 1373504

Expression cloning and characterization of the canine parietal cell gastrin receptor.

A S Kopin1, Y M Lee, E W McBride, L J Miller, M Lu, H Y Lin, L F Kolakowski, M Beinborn.   

Abstract

Gastrin is an important stimulant of acid secretion by gastric parietal cells and is structurally related to the peptide hormone cholecystokinin (CCK). The pharmacologic properties of the parietal cell gastrin receptor are very similar to the predominant CCK receptor in the brain, CCK-B. Neither the gastrin nor the CCK-B receptor have been cloned thus far, making it difficult to resolve whether these two receptors are distinct. We have isolated a clone encoding the canine gastrin receptor by screening a parietal cell cDNA expression library using a radioligand-binding strategy. Nucleotide sequence analysis revealed an open reading frame encoding a 453-amino acid protein with seven putative hydrophobic transmembrane domains and significant homology with members of the beta-adrenergic family of G protein-coupled receptors. The expressed recombinant receptor shows the same binding specificity for gastrin/CCK agonists and antagonists as the canine parietal cell receptor. Gastrin-stimulated phosphatidylinositol hydrolysis and intracellular Ca2+ mobilization in COS-7 cells expressing the cloned receptor suggest second-messenger signaling through phospholipase C. Affinity labeling of the expressed receptor in COS-7 cells revealed a protein identical in size to the native parietal cell receptor. Gastrin receptor transcripts were identified by high-stringency RNA blot analysis in both parietal cells and cerebral cortex, suggesting that the gastrin and CCK-B receptors are either highly homologous or identical.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1373504      PMCID: PMC48917          DOI: 10.1073/pnas.89.8.3605

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

Review 1.  Model systems for the study of seven-transmembrane-segment receptors.

Authors:  H G Dohlman; J Thorner; M G Caron; R J Lefkowitz
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

2.  Establishment of a new short, protease-resistant, affinity labeling reagent for the cholecystokinin receptor.

Authors:  R K Pearson; S P Powers; E M Hadac; H Gaisano; L J Miller
Journal:  Biochem Biophys Res Commun       Date:  1987-08-31       Impact factor: 3.575

3.  The detection and classification of membrane-spanning proteins.

Authors:  P Klein; M Kanehisa; C DeLisi
Journal:  Biochim Biophys Acta       Date:  1985-05-28

4.  Effect of rise in cAMP levels on Ca2+ influx through voltage-dependent Ca2+ channels in HIT cells. Second-messenger synarchy in beta-cells.

Authors:  A S Rajan; R S Hill; A E Boyd
Journal:  Diabetes       Date:  1989-07       Impact factor: 9.461

5.  Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist.

Authors:  R S Chang; V J Lotti
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

6.  Involvement of a pertussis toxin-sensitive G protein in the action of gastrin on gastric parietal cells.

Authors:  S Roche; J P Bali; R Magous
Journal:  Biochim Biophys Acta       Date:  1990-12-10

7.  Gastrin receptors on isolated canine parietal cells.

Authors:  A H Soll; D A Amirian; L P Thomas; T J Reedy; J D Elashoff
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

8.  Release of intracellular Ca2+ and elevation of inositol trisphosphate by secretagogues in parietal and chief cells isolated from rabbit gastric mucosa.

Authors:  C S Chew; M R Brown
Journal:  Biochim Biophys Acta       Date:  1986-08-29

9.  A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260.

Authors:  V J Lotti; R S Chang
Journal:  Eur J Pharmacol       Date:  1989-03-21       Impact factor: 4.432

10.  Cysteine residues 110 and 187 are essential for the formation of correct structure in bovine rhodopsin.

Authors:  S S Karnik; T P Sakmar; H B Chen; H G Khorana
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

View more
  93 in total

1.  L-365,260 inhibits in vitro acid secretion by interacting with a PKA pathway.

Authors:  C Oiry; J Pannequin; A Cormier; J C Galleyrand; J Martinez
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

Review 2.  Topical review. Gastrin and gastric epithelial physiology.

Authors:  G J Dockray
Journal:  J Physiol       Date:  1999-07-15       Impact factor: 5.182

3.  Mobilization of rat stomach ECL-cell histamine in response to short- or long-term treatment with omeprazole and/or YF 476 studied by gastric submucosal microdialysis in conscious rats.

Authors:  T Konagaya; M Bernsand; P Norlén; R Håkanson
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

4.  Thermodynamic analysis of ligands at cholecystokinin CCK2 receptors in rat cerebral cortex.

Authors:  E A Harper; S P Roberts; S B Kalindjian
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

5.  Flow cytometric detection of progastrin interaction with gastrointestinal cells.

Authors:  Alexander Dubeykovskiy; Thomas Nguyen; Zinaida Dubeykovskaya; Shi Lei; Timothy C Wang
Journal:  Regul Pept       Date:  2008-07-09

6.  Functional compensation between cholecystokinin-1 and -2 receptors in murine paraventricular nucleus neurons.

Authors:  Shahid Mohammad; Tomoya Ozaki; Kouhei Takeuchi; Katsuya Unno; Kurumi Yamoto; Eri Morioka; Soichi Takiguchi; Masayuki Ikeda
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

7.  Modulation of cholecystokinin activity by albumin.

Authors:  S C Huang; V D Talkad; K P Fortune; S Jonnalagadda; C Severi; G Delle Fave; J D Gardner
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

Review 8.  The production and role of gastrin-17 and gastrin-17-gly in gastrointestinal cancers.

Authors:  Jeffrey Copps; Richard F Murphy; Sándor Lovas
Journal:  Protein Pept Lett       Date:  2009       Impact factor: 1.890

9.  Localization of the murine cholecystokinin A and B receptor genes.

Authors:  L C Samuelson; M S Isakoff; K A Lacourse
Journal:  Mamm Genome       Date:  1995-04       Impact factor: 2.957

10.  Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat.

Authors:  A Schmassmann; A Garner; B Flogerzi; M Y Hasan; M Sanner; L Varga; F Halter
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.